1 / 1

Patient Characteristics

Clinical Outcomes for Tandem and Ring Brachytherapy for Cervix Cancer: The University of Washington Experience Benjamin King, M.D., Christopher Loiselle , M.D., Haleigh Werner, M.D., Thomas Carlson, M.D., and Wui -Jin Koh M.D . Patient Characteristics. Purpose. Results.

affrica
Download Presentation

Patient Characteristics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Clinical Outcomes for Tandem and Ring Brachytherapy for Cervix Cancer: The University of Washington Experience Benjamin King, M.D., Christopher Loiselle, M.D., Haleigh Werner, M.D., Thomas Carlson, M.D., and Wui-Jin Koh M.D. Patient Characteristics Purpose Results • Crude local control was 89.9% (125/139) and 3-year actuarial LC was 84.2% • Crude metastasis-free survival was 74.8% (104/139) and 3-year actuarial MFS was 64.6% • Crude overall survival was 84.9% (118/139) while 3-year actuarial OS was 77.8% • Patients with local recurrence had poor prognostic factors such as residual disease according to physical exam after external beam radiation (9 /14), pelvic sidewall invasion (7 of 14), positive pelvic nodes when assessed via surgical sampling or PET (7 of 11). • All recurrences (except one villogladular adenocarcinoma) had moderately or poorly differentiated histologies. • Definitive concurrent cisplatin-based chemo-radiation, is the standard of care for locally advanced carcinoma of the cervix. Brachytherapy is a crucial component of therapy. • There are differing approaches to brachytherapy, including low-dose-rate (LDR) and high-dose-rate (HDR) techniques, as well as the use of more traditional tandem and ovoids (T&O) versus newer tandem and ring (T&R) applicators. • The fixed geometry of T&R allows for greater inter-placement reproducibility, more rapid dosimetry planning, and hence increased patient comfort. • Others have questioned the geometry, radiation distribution, and tumor coverage of T&R compared to T&O. This retrospective study was performed to review clinical cancer control outcomes (local  control, metastasis free survival, and overall survival) at our institution using our HDR T&R brachytherapy boost method.  Local Control 3-year Local Control = 84.2% Methods Metastasis Free Survival • Retrospective review of 139 patients treated from 1997 through 2010 who underwent HDR T&R intracavitary brachytherapy as part of definitive therapy for cervical cancer. • Median total dose to Point A was 87.1 Gy (44-97 Gy). • Median dose per HDR brachytherapy fraction was 6 Gy (range 5-7.5 Gy). • Median follow up was 16 months, (range 0-95 months). • Local control was defined as cervical or vaginal control • Metastasis was defined as metastasis to sites outside the local and pelvic regions 3 –year Metastasis Free Survival = 64.6% Overall Survival Conclusions • Tandem and ring HDR brachytherapy is a feasible alternative to traditional T&O brachytherapy and achieves acceptable outcomes with respect to localcontrol. • Further study regarding acute and late toxicity will be performed. 3-year Overall Survival = 77.8% . Figure 1. The assembled tandem and ring applicator showing the cross braces fixing the tandem to ring at two points and providing rigidity and fixed geometry.

More Related